BioMarin Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
25.04.24
/
50%
€76.58
Target price
25.04.25
€102.61
Performance (%)
-0.55%
Price
09.05.24
€76.16
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for BioMarin Pharmaceutical Inc. is nearly unchanged. This prediction currently runs until 25.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | -0.600% |
iShares Core DAX® | 4.094% |
iShares Nasdaq 100 | 1.424% |
iShares Nikkei 225® | -1.572% |
iShares S&P 500 | 1.822% |
Comments by Cantor_Fitzgerald for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $110.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.34
23.02.24
23.02.24
€92.36
23.02.25
23.02.25
-9.70%
09.05.24
09.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.34
16.10.23
16.10.23
€113.65
16.10.24
16.10.24
-5.20%
09.05.24
09.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.26
13.09.23
13.09.23
€111.79
13.09.24
13.09.24
-10.67%
09.05.24
09.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€109.34
01.08.24
01.08.24
-4.47%
09.05.24
09.05.24